Patient-provider discussions about lung cancer screening pre- and post-guidelines: Health Information National Trends Survey (HINTS). Issue 11 (November 2016)

• Record Type: Journal Article
• Authors: Carter-Harris, Lisa; Tan, Andy S.L.; Salloum, Ramzi G.; Young-Wolff, Kelly C.
• Is Part Of: Patient education and counseling. Volume 99:Issue 11(2016)
• Page Start: 1772
• Page End: 1777
• Publication Date: 2016-11
• Subjects: Lung cancer screening -- Shared decision making -- Health communication -- Patient-provider discussion -- Health Information National Trends Survey -- HINTS; Patient education -- Periodicals; Health counseling -- Periodicals; Health education -- Periodicals; Counseling -- Periodicals; Patient Education -- Periodicals; Éducation des patients -- Périodiques; Counseling -- Périodiques; Éducation sanitaire -- Périodiques; 615.5071
• DOI: 10.1016/j.pec.2016.05.014
• Languages: English
• ISSNs: 0738-3991

Abstract

Highlights: Prevalence of patient-provider discussions about lung cancer screening is low. Patient and provider education is critical in lung cancer screening decisions. Addressing stigma is an important component of lung cancer screening education. Abstract: Objective: In 2013, the USPSTF issued a Grade B recommendation that long-term current and former smokers receive lung cancer screening. Shared decision-making is important for individuals considering screening, and patient-provider discussions an essential component of the process. We examined prevalence and predictors of lung cancer screening discussions pre- and post-USPSTF guidelines. Methods: Data were obtained from two cycles of the Health Information National Trends Survey (2012; 2014). The analyzed sample comprised screening-eligible current and former smokers with no personal history of lung cancer (n = 746 in 2012; n = 795 in 2014). Descriptive and multiple logistic regression analyses were conducted; patient-reported discussion about lung cancer screening with provider was the outcome of interest. Results: Contrary to expectations, patient-provider discussions about lung cancer screening were more prevalent pre-guideline, but overall patient-provider discussions were low in both years (17% in 2012; 10% in 2014). Current smokers were more likely to have had a discussion than former smokers. Significant predictors of patient-provider discussions included family history of cancer and having healthcare coverage. Conclusions: The prevalence of patient-provider discussions about lung cancer screening is suboptimal. Practice implications: There is a critical need for patient and provider education about shared decision-making and its importance in cancer screening decisions.